OPTIMER PHARMACEUTICALS INC Increase (Decrease) in Other Receivables
OPTIMER PHARMACEUTICALS INC reported Increase (Decrease) in Other Receivables of -$1.48 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC increase (decrease) in other receivables for the quarter ending 2013-06-30 was -$3.03M.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in other receivables for the quarter ending 2013-03-31 was $1.55M, a 9.03% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in other receivables for the quarter ending 2012-12-31 was $715.98K, a 98.62% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in other receivables for the quarter ending 2012-09-30 was -$1.51M.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in other receivables for fiscal 2012 was -$49.68M, a 195.01% decline from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in other receivables for fiscal 2011 was $52.29M.
- OPTIMER PHARMACEUTICALS INC increase (decrease) in other receivables for fiscal 2010 was -$30.61K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$1.48M 10-Q · filed 2013-08-07 | -$768.44K derived: sum of 3 quarters · filed 2013-08-07 | -$2.27M derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | $1.55M 10-Q · filed 2013-05-10 | $2.26M derived: sum of 2 quarters · filed 2013-05-10 | $757.90K derived: sum of 3 quarters · filed 2013-05-10 | -$49.55M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-12-31 | $715.98K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$790.25K derived: sum of 2 quarters · filed 2013-03-18 | -$51.10M derived: sum of 3 quarters · filed 2013-08-07 | -$49.68M 10-K · filed 2013-03-18 |
| 2012-09-30 | -$1.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$51.82M derived: sum of 2 quarters · filed 2013-08-07 | -$50.40M 10-Q · filed 2012-11-02 | $1.33M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | -$50.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$48.89M 10-Q · filed 2013-08-07 | $2.84M derived: sum of 3 quarters · filed 2013-08-07 | -$1.98M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-03-31 | $1.42M 10-Q · filed 2013-05-10 | $53.15M derived: sum of 2 quarters · filed 2013-05-10 | $48.33M derived: sum of 3 quarters · filed 2013-05-10 | |
| 2011-12-31 | $51.73M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $46.91M derived: sum of 2 quarters · filed 2013-03-18 | $52.29M 10-K · filed 2013-03-18 | |
| 2011-09-30 | -$4.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $560.99K 10-Q · filed 2012-11-02 | ||
| 2011-06-30 | $5.38M 10-Q · filed 2012-08-03 | |||
| 2010-12-31 | -$30.61K 10-K · filed 2013-03-18 |